遗传信息在保险实施中的应用:目前存在的问题及其解决前景

IF 0.1 Q4 LAW
V. Nikiforov, E. Suvorova, S. Zenin
{"title":"遗传信息在保险实施中的应用:目前存在的问题及其解决前景","authors":"V. Nikiforov, E. Suvorova, S. Zenin","doi":"10.18690/mls.13.1.93-104.2020","DOIUrl":null,"url":null,"abstract":"Increasing the efficiency of risk assessment for the purposes of personal insurance is impossible without using the latest achievements of modern science. This translates into a growing interest in the use of genetic research results by insurers, which manifests itself not only in legislation and insurers’ practices, but also in international recommendations on personal medical data processing for insurance purposes. Based on analysis of foreign practices, the authors determine priority areas of respective legislation development, in particular, legislative recognition of a ban on insurers’ access to genetic data in the context of obligatory medical insurance and group insurance programs; granting insurers the right to use genetic testing results for the purposes of life insurance, personal accident and sickness insurance, voluntary medical insurance, if the sum insured exceeds a statutory threshold.   The reported study was funded by Russian Foundation for Basic Research (RFBR) according to Research Project No. 18-29-14056.","PeriodicalId":54182,"journal":{"name":"MEDICINE AND LAW","volume":"14 1","pages":"93-104"},"PeriodicalIF":0.1000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Use of Genetic Information in the Implementation of Insurance: Current Problems and Prospects for their Solution\",\"authors\":\"V. Nikiforov, E. Suvorova, S. Zenin\",\"doi\":\"10.18690/mls.13.1.93-104.2020\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Increasing the efficiency of risk assessment for the purposes of personal insurance is impossible without using the latest achievements of modern science. This translates into a growing interest in the use of genetic research results by insurers, which manifests itself not only in legislation and insurers’ practices, but also in international recommendations on personal medical data processing for insurance purposes. Based on analysis of foreign practices, the authors determine priority areas of respective legislation development, in particular, legislative recognition of a ban on insurers’ access to genetic data in the context of obligatory medical insurance and group insurance programs; granting insurers the right to use genetic testing results for the purposes of life insurance, personal accident and sickness insurance, voluntary medical insurance, if the sum insured exceeds a statutory threshold.   The reported study was funded by Russian Foundation for Basic Research (RFBR) according to Research Project No. 18-29-14056.\",\"PeriodicalId\":54182,\"journal\":{\"name\":\"MEDICINE AND LAW\",\"volume\":\"14 1\",\"pages\":\"93-104\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MEDICINE AND LAW\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18690/mls.13.1.93-104.2020\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"LAW\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MEDICINE AND LAW","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18690/mls.13.1.93-104.2020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"LAW","Score":null,"Total":0}
引用次数: 0

摘要

提高人身保险风险评估的效率离不开现代科学的最新成果。这意味着保险公司对利用基因研究结果的兴趣日益浓厚,这不仅体现在立法和保险公司的做法中,而且体现在关于为保险目的处理个人医疗数据的国际建议中。根据对国外实践的分析,作者确定了各自立法发展的优先领域,特别是立法承认在强制性医疗保险和团体保险方案的背景下禁止保险公司获取基因数据;如果保险金额超过法定门槛,允许保险公司将基因检测结果用于人寿保险、人身意外和疾病保险、自愿医疗保险。报告的研究由俄罗斯基础研究基金会(RFBR)根据第18-29-14056号研究项目资助。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Use of Genetic Information in the Implementation of Insurance: Current Problems and Prospects for their Solution
Increasing the efficiency of risk assessment for the purposes of personal insurance is impossible without using the latest achievements of modern science. This translates into a growing interest in the use of genetic research results by insurers, which manifests itself not only in legislation and insurers’ practices, but also in international recommendations on personal medical data processing for insurance purposes. Based on analysis of foreign practices, the authors determine priority areas of respective legislation development, in particular, legislative recognition of a ban on insurers’ access to genetic data in the context of obligatory medical insurance and group insurance programs; granting insurers the right to use genetic testing results for the purposes of life insurance, personal accident and sickness insurance, voluntary medical insurance, if the sum insured exceeds a statutory threshold.   The reported study was funded by Russian Foundation for Basic Research (RFBR) according to Research Project No. 18-29-14056.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信